Introduction: The initiative of a consensus on the topic of antidepressant and anxiolytic drug
use in pregnancy is developing in an area of clinical uncertainty. Although many studies …

Importance Clinical decision-making on antidepressant treatment during pregnancy,
particularly selective serotonin reuptake inhibitors (SSRIs), is challenging, as both prenatal …

Introduction Depression is one of the most common co‐morbidities during pregnancy; with
severe symptoms, antidepressants are sometimes recommended. Social determinants are …

Importance Approximately one-half of women treated for affective disorders discontinue
antidepressant use during pregnancy, yet this discontinuation could lead to relapse post …

Background During pregnancy, both selective serotonin reuptake inhibitor (SSRI) exposure
and maternal depression have been associated with poor offspring neurodevelopmental …

Background Knowledge about the effectiveness of antidepressants in pregnancy is limited.
We aimed to evaluate the association of antidepressant continuation in pregnancy and …

Importance Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine
reuptake inhibitors (SNRIs) are consistently reported to be discontinued by approximately …

To the Editor We read with great interest the publication of Koc and colleagues on prenatal
exposure to selective serotonin reuptake inhibitors (SSRIs) and offspring brain trajectories. 1 …

To the Editor We read with great interest the publication of Koc and colleagues on prenatal
exposure to selective serotonin reuptake inhibitors (SSRIs) and offspring brain trajectories. 1 …

Perinatal mental health conditions have been associated with adverse pregnancy outcomes,
including maternal death. This quality improvement project analyzed pregnancy-associated …